Truist analyst Michael Ciarmoli lowered the firm’s price target on Northrop Grumman (NOC) to $550 from $600 and keeps a Buy rating on the shares post Q1. Results missed expectations and were negatively impacted by a surprise B-21 charge, the firm notes. While management reaffirmed its revenue/free cash flow outlook, it reduced its margins and EPS outlook for the year.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOC:
- Northrop Grumman price target lowered to $540 from $557 at Susquehanna
- Northrop Grumman price target lowered to $550 from $585 at BofA
- Northrop Grumman Reports Q1 2025 Financial Results
- Northrop Grumman’s Earnings Call: Achievements and Challenges
- Cautious Hold Rating for Northrop Grumman Amid Sales Shortfall and B-21 Program Challenges